Article Versions Notes

Oji Y, Kagawa N, Arita H, Naka N, Hamada K-i, Outani H, Shintani Y, Takeda Y, Morii E, Shimazu K, et al. WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1. Cancers. 2023; 15(2):393. https://doi.org/10.3390/cancers15020393

Oji, Yusuke, Naoki Kagawa, Hideyuki Arita, Norifumi Naka, Ken-ichiro Hamada, Hidetatsu Outani, Yasushi Shintani, Yoshito Takeda, Eiichi Morii, Kenzo Shimazu, and et al. 2023. "WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1" Cancers 15, no. 2: 393. https://doi.org/10.3390/cancers15020393

Oji, Y., Kagawa, N., Arita, H., Naka, N., Hamada, K.-i., Outani, H., Shintani, Y., Takeda, Y., Morii, E., Shimazu, K., Suzuki, M., Nishida, S., Nakata, J., Tsuboi, A., Iwai, M., Hayashi, S., Imanishi, R., Ikejima, S., Kanegae, M., ... Sugiyama, H. (2023). WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1. Cancers, 15(2), 393. https://doi.org/10.3390/cancers15020393